Immutep Ltd (STU:YP1B) Stock News, Headlines & Updates
Immutep Ltd Stock News from GuruFocus
- 1
Jun 23, 2025
Immutep (IMMP) Reports Promising Early Results in Autoimmune Treatment Study | IMMP Stock News
GuruFocus News • 1:22pm
Immutep Announces Positive Update from Phase I Study of IMP761, a First-in-Class LAG-3 Agonist Antibody for Autoimmune Diseases
Marketwired • 7:00am
May 27, 2025
Immutep (IMMP) Advances with Promising Phase II Trial Results | IMMP Stock News
GuruFocus News • 7:32am
Immutep's Efti with Radiotherapy & KEYTRUDA® (pembrolizumab) Meets Primary Endpoint in Phase II for Soft Tissue Sarcoma
Marketwired • 7:00am
May 15, 2025
Immutep (IMMP) Reports Strong Results from INSIGHT-003 Lung Cancer Trial | IMMP Stock News
GuruFocus News • 7:46am
Immutep's Efti with KEYTRUDA® (pembrolizumab) & Chemotherapy Achieves High Response Rates in First-Line Non-Small Cell Lung Cancer
Marketwired • 7:00am
May 05, 2025
Immutep (IMMP) Reports Promising Survival Data from TACTI-003 Phase IIb Trial | IMMP Stock News
GuruFocus News • 7:30am
Apr 29, 2025
Immutep Quarterly Activities Report Q3 FY25
Marketwired • 8:00am
Immutep (IMMP) Strengthens Financial Position with Strategic Cash Management | IMMP Stock News
GuruFocus News • 7:49am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news